TaiMed Biologics Inc. (4147.TWO)
TWD 82.5
(-0.48%)
TWD 82.5
(-0.48%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.89 Billion TWD | -5.05% |
| 2022 | 4.1 Billion TWD | -11.05% |
| 2021 | 4.61 Billion TWD | -11.27% |
| 2020 | 5.19 Billion TWD | 9.84% |
| 2019 | 4.73 Billion TWD | -1.26% |
| 2018 | 4.79 Billion TWD | 6.4% |
| 2017 | 4.5 Billion TWD | -6.22% |
| 2016 | 4.8 Billion TWD | -2.53% |
| 2015 | 4.92 Billion TWD | 161.95% |
| 2014 | 1.88 Billion TWD | 163.14% |
| 2013 | 714.71 Million TWD | 8.38% |
| 2012 | 659.44 Million TWD | -22.82% |
| 2011 | 854.39 Million TWD | -19.25% |
| 2010 | 1.05 Billion TWD | 71.42% |
| 2009 | 617.21 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 5.48 Billion TWD | 40.96% |
| 2024 Q2 | 5.24 Billion TWD | -4.53% |
| 2023 Q4 | 3.89 Billion TWD | -2.69% |
| 2023 Q1 | 4.04 Billion TWD | -1.48% |
| 2023 FY | 3.89 Billion TWD | -5.05% |
| 2023 Q3 | 4 Billion TWD | -0.36% |
| 2023 Q2 | 4.01 Billion TWD | -0.6% |
| 2022 Q2 | 4.47 Billion TWD | -5.5% |
| 2022 Q1 | 4.73 Billion TWD | 2.7% |
| 2022 FY | 4.1 Billion TWD | -11.05% |
| 2022 Q4 | 4.1 Billion TWD | -7.84% |
| 2022 Q3 | 4.45 Billion TWD | -0.55% |
| 2021 Q4 | 4.61 Billion TWD | -4.09% |
| 2021 Q2 | 4.86 Billion TWD | -2.92% |
| 2021 Q1 | 5.01 Billion TWD | -3.49% |
| 2021 Q3 | 4.8 Billion TWD | -1.26% |
| 2021 FY | 4.61 Billion TWD | -11.27% |
| 2020 Q3 | 5.21 Billion TWD | -2.63% |
| 2020 FY | 5.19 Billion TWD | 9.84% |
| 2020 Q1 | 5 Billion TWD | 5.7% |
| 2020 Q2 | 5.35 Billion TWD | 7.17% |
| 2020 Q4 | 5.19 Billion TWD | -0.42% |
| 2019 Q4 | 4.73 Billion TWD | -4.12% |
| 2019 FY | 4.73 Billion TWD | -1.26% |
| 2019 Q1 | 4.69 Billion TWD | -1.98% |
| 2019 Q2 | 4.98 Billion TWD | 6.22% |
| 2019 Q3 | 4.93 Billion TWD | -1.08% |
| 2018 FY | 4.79 Billion TWD | 6.4% |
| 2018 Q4 | 4.79 Billion TWD | -1.12% |
| 2018 Q3 | 4.84 Billion TWD | -7.07% |
| 2018 Q2 | 5.21 Billion TWD | 5.99% |
| 2018 Q1 | 4.91 Billion TWD | 9.24% |
| 2017 FY | 4.5 Billion TWD | -6.22% |
| 2017 Q4 | 4.5 Billion TWD | -3.18% |
| 2017 Q3 | 4.65 Billion TWD | -4.59% |
| 2017 Q2 | 4.87 Billion TWD | 0.61% |
| 2017 Q1 | 4.84 Billion TWD | 0.9% |
| 2016 Q3 | 4.84 Billion TWD | -0.62% |
| 2016 Q1 | 4.92 Billion TWD | -0.0% |
| 2016 FY | 4.8 Billion TWD | -2.53% |
| 2016 Q4 | 4.8 Billion TWD | -0.85% |
| 2016 Q2 | 4.87 Billion TWD | -1.08% |
| 2015 Q3 | 1.66 Billion TWD | -5.79% |
| 2015 FY | 4.92 Billion TWD | 161.95% |
| 2015 Q4 | 4.92 Billion TWD | 196.61% |
| 2015 Q2 | 1.76 Billion TWD | -2.75% |
| 2015 Q1 | 1.81 Billion TWD | -3.61% |
| 2014 Q2 | 1.98 Billion TWD | 0.0% |
| 2014 Q4 | 1.88 Billion TWD | 0.0% |
| 2014 Q1 | - TWD | -100.0% |
| 2014 FY | 1.88 Billion TWD | 163.14% |
| 2013 Q1 | 828.64 Million TWD | 25.66% |
| 2013 Q2 | 828.64 Million TWD | 0.0% |
| 2013 Q3 | 714.71 Million TWD | -13.75% |
| 2013 Q4 | 714.71 Million TWD | 0.0% |
| 2013 FY | 714.71 Million TWD | 8.38% |
| 2012 Q3 | 898.16 Million TWD | 15.94% |
| 2012 Q2 | 774.66 Million TWD | 0.0% |
| 2012 Q4 | 659.44 Million TWD | -26.58% |
| 2012 FY | 659.44 Million TWD | -22.82% |
| 2011 FY | 854.39 Million TWD | -19.25% |
| 2011 Q2 | 947.55 Million TWD | 0.0% |
| 2011 Q4 | 854.39 Million TWD | 0.0% |
| 2010 Q4 | 1.05 Billion TWD | 0.0% |
| 2010 FY | 1.05 Billion TWD | 71.42% |
| 2009 FY | 617.21 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -1371.309% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -243.427% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -2532.202% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -313.472% |
| NaviFUS Corp. | 490.53 Million TWD | -693.811% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -340.94% |
| TaiRx, Inc. | 833.74 Million TWD | -367.039% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -185.609% |
| Lin BioScience, Inc. | 3.59 Billion TWD | -8.263% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -5193.676% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -135.101% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2941.01% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -34.232% |
| AP Biosciences Inc | 890.75 Million TWD | -337.148% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -80.355% |
| RBC Bioscience Corporation | 753.79 Million TWD | -416.579% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | -25.358% |
| EirGenix Inc. | 11.16 Billion TWD | 65.116% |
| Enimmune corporation | 604.82 Million TWD | -543.808% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -782.593% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -118.923% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -1101.279% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | -3.276% |
| TCI GENE Inc. | 1.16 Billion TWD | -233.973% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -929.153% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 74.655% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -849.14% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -1193.524% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -609.601% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -881.205% |
| Neith Corporation | 192.15 Million TWD | -1926.47% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -127.4% |
| VBI | 452.1 Million TWD | -761.293% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -87.576% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -231.076% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -235.765% |
| CHO Pharma, Inc. | 3.08 Billion TWD | -26.179% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -635.888% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -1221.851% |
| Visgeneer Inc. | 397.17 Million TWD | -880.402% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -235.282% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -579.403% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -217.685% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -485.796% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -270.68% |
| GlycoNex Incorporation | 1.55 Billion TWD | -150.766% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 54.336% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -191.976% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 1.517% |
| Intech Biopharm Corporation | 2.71 Billion TWD | -43.631% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -420.181% |
| BiOptic Inc. | 613.77 Million TWD | -534.424% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -216.621% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -185.618% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -457.508% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 30.514% |
| Savior Lifetec Corporation | 3.82 Billion TWD | -1.864% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -503.85% |
| Level Biotechnology Inc. | 822.67 Million TWD | -373.326% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 36.088% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -266.657% |
| Acepodia, Inc. | 6.81 Billion TWD | 42.892% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | -1.762% |